FibroGen (FGEN)
(Delayed Data from NSDQ)
$6.91 USD
-0.02 (-0.29%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $7.04 +0.13 (1.88%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, FibroGen, Inc has a market cap of $28.01M, which represents its share price of $6.93 multiplied by its outstanding shares number of 4.04M. As a small-cap company, FGEN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FGEN 6.91 -0.02(-0.29%)
Will FGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FGEN
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
FGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Akebia Therapeutics (AKBA) Reports Q4 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates
Other News for FGEN
Vanguard Group Inc Reduces Stake in FibroGen Inc
FibroGen to Report Second Quarter 2025 Financial Results | FGEN Stock News
Foresight Environmental Infrastructure Limited Adjusts Share Capital with Treasury Purchase
Director Makes Bold Move with Major FibroGen Stock Purchase
12 Health Care Stocks Moving In Wednesday's After-Market Session